Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease

被引:18
|
作者
Bochenek, Grazyna [1 ]
Szafraniec, Krystyna [2 ]
Kuschill-Dziurda, Joanna [1 ]
Nizankowska-Mogilnicka, Ewa [1 ]
机构
[1] Jagiellonian Univ, Dept Internal Med, Coll Med, PL-31066 Krakow, Poland
[2] Jagiellonian Univ, Dept Epidemiol & Populat Studies, Coll Med, Fac Hlth Sci, PL-31531 Krakow, Poland
关键词
Aspirin-exacerbated respiratory disease; Asthma control; Asthma control test; Asthma phenotype; Nonsteroidal anti-inflammatory drugs; STAPHYLOCOCCUS-AUREUS ENTEROTOXINS; QUALITY-OF-LIFE; NATURAL-HISTORY; RISK-FACTORS; IGE; PREVALENCE; SEVERITY; ADULTS; SERUM;
D O I
10.1016/j.rmed.2015.02.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Effective control of asthma is the primary goal of its treatment. Despite an improved understanding of asthma pathogenesis and accessibility of novel therapies, the rate of uncontrolled asthma remains high. Objective: To find potential factors associated with asthma control in patients with aspirin-exacerbated respiratory disease (AERD). Methods:Clinical data were collected from a specifically structured questionnaire. Demographics, a history of upper airway symptoms, asthma course, exacerbations expressed as emergency department (ED) visits/hospitalizations, and asthma treatment were considered. Spirometry, skin prick tests, total IgE concentration, and blood eosinophil count were evaluated. Asthma control was assessed through the Asthma Control Test (ACT). Results: Out of 201 AERD patients, 41 (20.4%), 69 (34.3%), and 91 (45.3%) had controlled, partially controlled, and uncontrolled asthma, respectively. A multivariate ordered logistic regression analysis revealed that hospitalizations for asthma in the previous 12 months (OR 2.88; 95%CI, 1.117.46), ED visits for asthma throughout its duration (OR 1.05; 95%CI, 1.0041.10), and total IgE concentration (OR 1.28; 95%CI, 1.021.60) were positively associated with poor asthma control, whereas FEV1 values (OR 0.98; 95%CI, 0.960.99) and medical care at a referential specialty clinic (OR 0.50; 95%CI, 0.270.95) were positively associated with good asthma control. Conclusions: The prevalence of uncontrolled asthma in AERD patients is high and similar to that observed in different asthmatic populations. Owing both to the specificity and complexity of the disease, AERD patients should stay under regular care of well experienced referential medical centers to ensure that this asthma phenotype is dealt with effectively.
引用
收藏
页码:588 / 595
页数:8
相关论文
共 50 条
  • [1] FACTORS ASSOCIATED WITH UNCONTROLLED SEVERE ASTHMA IN PATIENTS WITH ASPIRIN-EXACERBATED RESPIRATORY DISEASE
    Mitsui, Chihiro
    Taniguchi, Masami
    Fukutomi, Yuma
    Ono, Emiko
    Higashi, Noritaka
    Mita, Haruhisa
    Akiyama, Kazuo
    RESPIROLOGY, 2013, 18 : 13 - 13
  • [2] Risk factors and characteristics associated with uncontrolled severe asthma in patients with aspirin-exacerbated respiratory disease
    Mitsui, C.
    Taniguchi, M.
    Fukutomi, Y.
    Higashi, N.
    Ono, E.
    Kajiwara, K.
    Tanimoto, H.
    Oshikata, C.
    Sekiya, K.
    Tsuburai, T.
    Tsurikisawa, N.
    Ishii, T.
    Mori, A.
    Mita, H.
    Hasegawa, M.
    Akiyama, K.
    ALLERGY, 2011, 66 : 364 - 364
  • [3] Perimenstrual Asthma in Aspirin-Exacerbated Respiratory Disease
    Eid, Ryan C.
    Palumbo, Marina L.
    Cahill, Katherine N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 573 - +
  • [4] Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma
    Erdogan, T.
    Karakaya, G.
    Kalyoncu, A. F.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (05) : 442 - 448
  • [5] Aspirin-Exacerbated Respiratory Disease
    Walgama, Evan S.
    Hwang, Peter H.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (01) : 83 - +
  • [6] Aspirin-exacerbated respiratory disease
    Wangberg, Hannah
    White, Andrew A.
    CURRENT OPINION IN IMMUNOLOGY, 2020, 66 : 9 - 13
  • [7] Platelets in patients with aspirin-exacerbated respiratory disease
    Laidlaw, Tanya M.
    Boyce, Joshua A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (06) : 1407 - 1415
  • [8] Aspirin-Exacerbated Respiratory Disease
    White, Andrew A.
    Stevenson, Donald D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1060 - 1070
  • [9] Aspirin-exacerbated respiratory disease
    Randerath, W. J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (11) : 541 - 546
  • [10] Social factors associated with aspirin desensitization and diagnosis age in aspirin-exacerbated respiratory disease
    Asthana, Shravan
    Workman, Alan D.
    Lerner, David K.
    Randell, Rani M.
    Lopez, Dana F.
    Kohanski, Michael A.
    Palmer, James N.
    Adappa, Nithin D.
    Douglas, Jennifer E.
    Bosso, John V.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2025, 15 (01) : 89 - 92